CD274 and melanoma: The programmed cell death receptor/programmed cell death ligand 1 (PD-1/PD-L1) axis is a known pathway exploited by neoplasms to evade immune surveillance (17, 18), inhibition of which has demonstrated clinical efficacy in melanoma and malignancies of the lung (19, 20).